Irritable Bowel Syndrome News

Patients with refractory irritable bowel syndrome indicated better illness-related quality of life after undergoing gut-directed group hypnotherapy in addition to medical treatment in a recent study.

Low mast cell counts and atopic disease are associated with increased risk for irritable bowel syndrome, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio.

Severity of gastrointestinal symptoms among women with irritable bowel syndrome was influenced by episodes of binge drinking in a recent study.

Dietary glutamate might have contributed to recurrent symptoms in some patients with fibromyalgia, according to study results.

LAS VEGAS — Biologic-naive patients with IBD who treated with infliximab and received methotrexate as an adjuvant therapy experienced similar outcomes to those who received azathioprine in a study presented at the 2012 American College of Gastroenterology Annual Scientific Meeting.

LAS VEGAS — Patients with IBS are more likely to develop osteoporosis and are at increased risk for osteoporosis-related fractures, according to data presented at the 2012 American College of Gastroenterology Annual Scientific Meeting.

Patients with IBS reported more use of proton pump inhibitors and nonsteroidal anti-inflammatory drugs before onset of their symptoms than controls in a recent study.

Patients with celiac disease had three times the risk for developing systemic lupus erythematosus compared with the general population, according to study data.

Patients with IBS treated with a symbiotic mixture experienced a decrease in the severity of flatulence symptoms, with no adverse events, in a recent study.

Prevalence of IBS varied according to a number of factors, including geographic location, diagnostic criteria for the illness, age and gender, according to a recent meta-analysis.